Table 3. The AYLL per patient, for 17 tumour sites, in order of descending AYLL.
| Site | AYLL (years) | % YLL |
|---|---|---|
| Brain+CNS | 20.1 | 3.4 |
| Cervix | 17.3 | 1.7 |
| Ovary | 16.3 | 3.6 |
| Melanoma | 15.1 | 1.4 |
| Leukaemia | 13.6 | 3.0 |
| Breast | 13.5 | 13.0 |
| NHL | 13.3 | 3.2 |
| Kidney | 12.8 | 2.0 |
| Pancreas | 12.0 | 3.6 |
| Lung | 11.8 | 18.2 |
| Oesophagus | 11.2 | 2.7 |
| Stomach | 11.1 | 5.2 |
| Uterus | 11.0 | 1.4 |
| Myeloma | 10.3 | 1.6 |
| Colon+rectum (+anus) | 9.8 | 12.0 |
| Bladder | 7.3 | 2.9 |
| Prostate | 6.1 | 4.7 |
| Total | 83.9% |
The variation in cancer burden per affected patient varies dramatically according to tumour type. The mean AYLL is 12.5 years. The % YLL for each site is shown for comparison (as Table 2). YLL=years of life lost; AYLL=avereage years of life lost.